The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

BACKGROUND: Immune checkpoint blockades (ICBs) are characterized by a durable clinical response and better tolerability in patients with a variety of advanced solid tumors. However, we not infrequently encounter patients with hyperprogressive disease (HPD) exhibiting paradoxically accelerated tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seo Ree, Chun, Sang Hoon, Kim, Joo Ri, Kim, Sang-Yeob, Seo, Jun Young, Jung, Chan Kwon, Gil, Bo-Mi, Kim, Jeong-Oh, Ko, Yoon Ho, Woo, In Sook, Shim, Byoung Yong, Hong, Sook-Hee, Kang, Jin Hyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786505/
https://www.ncbi.nlm.nih.gov/pubmed/33402127
http://dx.doi.org/10.1186/s12885-020-07727-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786505/
https://www.ncbi.nlm.nih.gov/pubmed/33402127
http://dx.doi.org/10.1186/s12885-020-07727-y

Ejemplares similares